Quick Takeaways
- Xinzhou Li has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $54,300.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Xinzhou Li
- Location
- Shanghai, China
- Summary
- The estimated net worth of Xinzhou Li is at least $54,300 dollars as of 25 May 2021. Xinzhou Li is the Director, 10%+ Owner of NovaBay Pharmaceuticals, Inc. and owns shares of NovaBay Pharmaceuticals, Inc. (NBY) stock worth about $54.3K.
- Signature
- /s/ Justin Hall as attorney in fact for Xinzhou Li
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Xinzhou Li and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: NovaBay Pharmaceuticals, Inc. ($54,300).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Xinzhou Li
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals, Inc. | Director, 10%+ Owner | $54,300 | 21 May 2021 |
Insider Transactions Reported by Xinzhou Li:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.